Prices & performance Investment updates Latest insights Invest now
Prices & performance Investment updates Latest insights Invest now

Please note the name of the Antipodes Asia Income Fund changed from the Premium Asia Income Fund on 22 April 2024.

Antipodes Asia Income Fund

The Antipodes Asia Income Fund is managed using a disciplined value-oriented approach supported by intensive, on-the-ground bottom-up fundamental research resulting in a concentrated portfolio of fixed interest securities issued by companies in Asia and the Middle East, which, in the view of the investment manager, are undervalued, on either an absolute or a relative basis, have the potential to generate regular income and have the potential for some capital appreciation.

This product is intended for use as a minor or satellite portfolio allocation for a consumer who is seeking capital growth and has a medium or high risk and return profile for that portion of their investment portfolio. It is likely to be consistent with the financial situation and needs of a consumer with a minimum 3-to-5-year investment timeframe and who is unlikely to need to withdraw their money on less than one week’s notice.

Key facts

wdt_ID Title Detail
1 Investment manager Antipodes Partners Limited
21 Sub investment manager Value Partners
22 Responsible entity Equity Trustees Limited
23 Strategy Emerging Markets Fixed Interest
24 Investment objective The Fund seeks current income and some capital appreciation by investing mostly in a diversified portfolio of high yielding, sub investment grade securities and non-rated securities across a range of markets in Asia and the Middle East.
26 Suggested minimum investment period 3 to 5 years
27 Risk Medium
28 Portfolio Allocation1 20-100% Asian, Middle Eastern and Commonwealth Independent States fixed interest securities
0-80% Cash
29 Registration Australia
30 Dealing frequency & cut-off Daily / 2pm Sydney
31 Distribution frequency Quarterly
32 Minimum initial investment A$25,000
33 Minimum additional investment A$10,000
34 Strategy inception date Aug-11
36 APIR MAQ0782AU
37 ARSN 151 270 423
40 Bloomberg code MAQ0782:AU

1The portfolio allocation ranges provided are indicative only. The Fund will be rebalanced within a reasonable period of time should the exposure move outside these ranges.

Net performance

Returns greater than 1 year are annualised. Past performance is no indication of future performance.1Inception is 31 August 2011.

The Fund was previously known as the Premium Asia Income Fund. Antipodes Partners Limited has appointed Value Partners under a sub-investment manager agreement to undertake portfolio management of the Fund. Value Partners have been the Investment Manager of this Fund since its inception.

Performance chart

Cumulative performance (over selected time horizon)

Antipodes Asia Income Fund

Returns greater than 1 year are annualised. Past performance is no indication of future performance. Calculations are based on exit price with distributions reinvested.

Unit price history

Distribution history

 

Portfolio profile as at 31st October 2024

Top 10 holdings (%)

Sector exposure (%)2

Portfolio characteristics and product composition (%)

Regional exposure (%)1, 3

1 Where possible, regions, countries and currencies classified on a look through basis. 2 GICS Classification. 3 Antipodes Partners classification.

Monthly updates

For historical reports, please contact the Antipodes team

Quarterly updates

For historical reports, please contact the Antipodes team

mFund

Annual Financial Statement

Other Documents

Invest

If you are applying using paper application forms, the minimum investment in the Antipodes Asia Income Fund is $25,000 for new investors and $10,000 for existing investors.

Who may invest in the fund

This fund is open to investors from Australia and New Zealand.

Important information

It is a legal requirement to download and read the Product Disclosure Statement before proceeding and we recommend that you consult a licensed financial advisor before making investment decisions.

Download Product Disclosure Statement (PDS).
Download Product Disclosure Statement (PDS) – NZ.
Download Target Market Determination (TMD).

Apply online

The application below allows you to invest in the Antipodes Asia Income Fund.

If you are applying using paper application forms, the minimum investment in the Antipodes Asia Income Fund is $25,000 for new investors and $10,000 for existing investors.

Apply online

Apply via a paper form

Purchase, top-up or sell a managed fund investment the familiar way.

  1. Download an application form here
  2. Complete the application form & sign
  3. Provide certified copies of your identity to verify your identity
  4. Email service@pinnacleinvestment.com

Download an application form.

Check out our investing tools

Our latest insights

Invest online now

Ratings

The Antipodes Asia Income Fund has been rated “Investment Grade” by Lonsec Research and “Superior” by SQM Research.

 

   

Important information

Equity Trustees Limited (“Equity Trustees”) (ABN 46 004 031 298), AFSL 240975, is the Responsible Entity for the Antipodes Asia Income Fund (“the Fund”).  Equity Trustees is a subsidiary of EQT Holdings Limited (ABN 22 607 797 615), a publicly listed company on the Australian Securities Exchange (ASX: EQT).

This webpage has been prepared by Antipodes Partners Limited (‘Antipodes’) (ABN 29 602 042 035, AFSL 481 580) as the investment manager of the Fund to provide you with general information only. In preparing this webpage, we did not take into account the investment objectives, financial situation or particular needs of any particular person. It is not intended to take the place of professional advice and you should not take action on specific issues in reliance on this information. Neither Antipodes, Equity Trustees nor any of its related parties, their employees or directors, provide and warranty of accuracy or reliability in relation to such information or accepts any liability to any person who relies on it. Past performance should not be taken as an indicator of future performance. You should obtain a copy of the Product Disclosure Statement before making a decision about whether to invest in this product.

Antipodes Asia Income Fund’s Target Market Determination is available here. A Target Market Determination is a document which is required to be made available from 5 October 2021. It describes who this financial product is likely to be appropriate for (i.e. the target market), and any conditions around how the product can be distributed to investors. It also describes the events or circumstances where the Target Market Determination for this financial product may need to be reviewed.

Past performance is not a reliable indicator of future performance and the repayment of capital is not guaranteed. The specific risks associated with investing in the Fund, and the risks associated with the Fund’s investments, are discussed in Section 3 of the PDS. Any opinions and forecasts reflect the judgment and assumptions of Antipodes and its representatives on the basis of information available as at the date of publication and may later change without notice.

The Lonsec Rating (assigned as follows: Antipodes Asia Income Fund – September 2023) presented in this document are published by Lonsec Research presented in this document are published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421445. The Ratings are limited to “General Advice” (as defined in the Corporations Act 2001 (Cth)) and based solely on consideration of the investment merits of the financial products. Past performance information is for illustrative purposes only and is not indicative of future performance. They are not a recommendation to purchase, sell or hold Antipodes products, and you should seek independent financial advice before investing in these products. The Ratings are subject to change without notice and Lonsec assumes no obligation to update the relevant documents following publication. Lonsec receives a fee from the Fund Manager for researching the products using comprehensive and objective criteria. For further information regarding Lonsec’s Ratings methodology, please refer to our website at https://www.lonsec.com.au/.

The rating contained on this page is issued by SQM Research Pty Ltd ABN 93 122 592 036AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.